![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 21, 13117-13122, Nov, 1984
T Watanabe, MM Smith, FW Robinson and T Kono
The mechanism of insulin action on glucose transport in rat hearts was studied. The glucose transport activity was determined after reconstitution into egg lecithin liposomes. Isolated rat hearts were perfused in the presence or absence of insulin and homogenized. The homogenate was fractionated by differential and sucrose density gradient centrifugations. Two subcellular fractions, designated as Fractions P-5 and P-6, contained glucose transport activity. Both fractions were enriched with 5'-nucleotidase (commonly known as a plasma membrane marker) and UDP-Gal:N-acetylglucosamine galactosyltransferase (known as a Golgi marker). However, only Fraction P-5 was concentrated with the insulin receptor and ouabain-sensitive p- nitrophenylphosphatase (both plasma membrane markers). The sedimentation properties of the glucose transport activity in Fraction P-6 were considerably different from those of galactosyltransferase. Insulin added to the heart before homogenization increased the glucose transport activity in Fraction P-5 approximately 1.6-fold while decreasing the activity in Fraction P-6 to approximately 62% of the control. These results are interpreted as follows. Both Fractions P-5 and P-6 are heterogeneous; nevertheless, Fraction P-5, but not Fraction P-6, may be enriched with the plasma membrane, which is assumed to be associated with glucose transport activity. Fraction P-6 may be concentrated with the Golgi apparatus; however, the latter may not be the structure (or vesicles) to which (intracellular) glucose transport activity is associated. Insulin appears to increase the glucose transport activity in rat hearts, at least in part, by inducing translocation of the glucose transport mechanism from the unidentified vesicles (in Fraction P-6) to the plasma membrane (in Fraction P-5).
This article has been cited by other articles:
![]() |
E. J. Miller, J. Li, K. M. Sinusas, G. D. Holman, and L. H. Young Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1922 - E1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kaneta, Y. Takai, Y. Kagaya, Y. Yamane, H. Wada, M. Yuki, R. Iwata, M. Tsujitani, S. Takahashi, and S. Yamada Imaging of Ischemic but Viable Myocardium Using a New 18F-Labeled 2-Nitroimidazole Analog, 18F-FRP170 J. Nucl. Med., January 1, 2002; 43(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Botker, H. Wiggers, M. Bottcher, J. S. Christiansen, T. T. Nielsen, A. Gjedde, and O. Schmitz Short-term effects of growth hormone on myocardial glucose uptake in healthy humans Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1053 - E1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Depre, J.-L. J. Vanoverschelde, and H. Taegtmeyer Glucose for the Heart Circulation, February 2, 1999; 99(4): 578 - 588. [Full Text] [PDF] |
||||
![]() |
C. Depre, V. Gaussin, S. Ponchaut, Y. Fischer, J.-L. Vanoverschelde, and L. Hue Inhibition of myocardial glucose uptake by cGMP Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1443 - H1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Brownsey, A. N. Boone, and M. F. Allard Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms Cardiovasc Res, April 1, 1997; 34(1): 3 - 24. [Full Text] [PDF] |
||||
![]() |
J. R. Sowers Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology Hypertension, March 1, 1997; 29(3): 691 - 699. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |